Lindsey Robinson
Family · Warner Robins, GANPI 1992436604
Payments from drug & device makers
Across 73 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$282
- Pfizer$199
- AstraZeneca$180
- Sumitomo Pharma America, Inc.$138
- Lilly USA, LLC$129
- Bayer$72
- plus $410 from 16 others
What the payments were for
- Food & beverage$1,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $282 |
| Pfizer | 10 | $199 |
| AstraZeneca | 9 | $180 |
| Sumitomo Pharma America, Inc. | 7 | $138 |
| Lilly USA, LLC | 7 | $129 |
| Bayer | 3 | $72 |
| Amgen | 4 | $63 |
| AbbVie | 2 | $49 |
| GSK | 2 | $36 |
| Exact Sciences | 2 | $30 |
| Lundbeck LLC | 1 | $24 |
| Johnson & Johnson | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Abbott | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Medtronic | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
How this compares
$1,411 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $43,429 |
| EliquisApixaban | 45 | $25,400 |
| JardianceEmpagliflozin | 24 | $18,337 |
| FarxigaDapagliflozin Propanediol | 13 | $9,987 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,723 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,246 |
| Memantine Hcl | 41 | $2,516 |
| Divalproex Sodium | 30 | $1,449 |
| Sertraline Hcl | 51 | $1,225 |
| Levothyroxine Sodium | 99 | $1,046 |
| Ezetimibe | 23 | $825 |
| Rosuvastatin Calcium | 29 | $758 |
| Bupropion XlBupropion Hcl | 26 | $754 |
| Losartan Potassium | 101 | $692 |
| Alendronate Sodium | 13 | $672 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $282 | $43,42940 claims |
| PfizerEliquis | $199 | $25,40045 claims |
| Boehringer IngelheimJardiance | $15 | $18,33724 claims |
| AstraZenecaFarxiga, Symbicort | $180 | $13,23325 claims |
| GSKTrelegy Ellipta | $36 | $8,72312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.
Other family in Warner Robins
- Kelly MurrayWarner Robins$18K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.